ライフサイエンスコーパス: health care cost

1 h in-hospital mortality, length of stay, and health care cost.

2 f infection following LT, and higher overall health care cost.

3 interval 1.17, 1.48) times the total annual health care cost.

4 n morbidity, mortality, quality of life, and health-care cost.

5 rtunities to enhance care quality and reduce health care costs.

6 ietal concern and generate significant human health care costs.

7 es morbidity, duration of hospital stay, and health care costs.

8 l as broad societal effects with substantial health care costs.

9 dialysis and is a significant contributor to health care costs.

10 nd population health outcomes while reducing health care costs.

11 lly save approximately 80 million dollars in health care costs.

12 otential effect of such urine RNA testing on health care costs.

13 ates, improve cosmetic outcome, and decrease health care costs.

14 nificant morbidity, mortality, and increased health care costs.

15 edical conditions and resultant reduction in health care costs.

16 of people each year and add significantly to health care costs.

17 ducing PAD-related morbidity, mortality, and health care costs.

18 es and QOL for patients with ESLD and reduce health care costs.

19 ntified as an opportunity for containment of health care costs.

20 nd late sequelae, accounting for substantial health care costs.

21 ed with RSV or influenza by assigning direct health care costs.

22 health care and a primary driver of growing health care costs.

23 oring tests was associated with higher total health care costs.

24 ratory diagnostic testing leads to increased health care costs.

25 beral threshold with respect to morbidity or health care costs.

26 Cancer-related expenditures are increasing health care costs.

27 d mental distress and a substantial cause of health care costs.

28 ury stage, patient participation in care and health care costs.

29 disease, antibiotic-related toxicities, and health care costs.

30 not associated with significant reduction in health care costs.

31 cosmetic problems, and its repair increases health care costs.

32 ed inpatient stays being a primary driver of health care costs.

33 ure to the health care setting, and decrease health care costs.

34 elative to their prevalence, impairment, and health care costs.

35 ssion, improve patient outcomes, and control health care costs.

36 sk for suicide, lost workdays, and increased health care costs.

37 e represents an effective approach to reduce health care costs.

38 icant morbidity and mortality and additional health care costs.

39 tes, improve cosmetic outcomes, and decrease health care costs.

40 HEN improves clinical outcomes and decreases health care costs.

41 stigmatization, patient distress, and higher health care costs.

42 is a major cause of morbidity and increased health care costs.

43 th increasing life expectancy and decreasing health care costs.

44 tes, improve cosmetic outcomes, and decrease health care costs.

45 eliminate unnecessary procedures, and reduce health care costs.

46 ve postoperative outcomes and reduce overall health care costs.

47 bstantially reduce morbidity, mortality, and health care costs.

48 e used to assess time to treatment and total health care costs.

49 are associated with increased morbidity and health care costs.

50 trends on the associated disease burden and health care costs.

51 f surgery is more likely to reduce long-term health care costs.

52 pirical evidence to anticipate the effect on health care costs.

53 rior resection increased mortality rates and health care costs.

54 e major sources of morbidity, mortality, and health care costs.

55 medical and mental disorders, and increased health care costs.

56 e airway pressure, patient satisfaction, and health care costs.

57 e, unnecessary antibiotic use, and increased health care costs.

58 ng among this cohort is critical to reducing health care costs.

59 d is associated with increased morbidity and health care costs.

60 oblem, resulting in substantial increases in health care costs.

61 ancer Quality of Life Questionnaire C30) and health care costs.

62 28) per patient and did not lower subsequent health care costs.

63 substantially increase non-Hodgkin lymphoma health care costs.

64 condition is causing a substantial burden on health care costs.

65 re associated with substantial morbidity and health care costs.

66 is associated with significant morbidity and health care costs.

67 s, 19,500 deaths, and $3.5 billion in direct health care costs.

68 fects, conserve the blood supply, and reduce health care costs.

69 , impaired work productivity and significant health care costs.

70 infected patients would substantially affect health care costs.

71 rams to improve employee health and decrease health care costs.

72 alence is increasing, with high societal and health care costs.

73 ted States and are associated with increased health care costs.

74 ive better outcomes in the setting of rising health care costs.

75 reby improving patient outcomes and reducing health care costs.

76 that affects both clinical care and overall health care costs.

77 nditions are the leading causes of death and health-care costs.

78 d morbidity and mortality rates, and soaring health-care costs.

79 ted with morbidity, mortality, and increased health-care costs.

80 clinicians to take leadership in reining in health-care costs.

81 ssary would improve infant health and reduce health-care costs.

82 ng the added years, and substantially reduce health-care costs.

83 ted morbidities, and increased mortality and health-care costs.

84 iduals, cardiovascular events prevented, and health-care costs.

85 audiovisual programme, so might also reduce health-care costs.

86 f asthma control, patient acceptability, and health-care costs.

87 is associated with poor health and increased health-care costs.

88 5.61 vs. 28.99; P < 0.0001) and total annual health care costs ($19,476 vs. $23,605; P < 0.0001) comp

89 tal claims (28.99 vs. 25.19; P < 0.0001) and health care costs ($23,605 vs. $18,228; P < 0.0001) in H

90 and improve outcomes while reducing overall health care costs ( 7 , 8 ).

91 Health-care costs accounted for euro8 billion (75% of to

92 The outcomes measured were health-care costs accrued in the last year of life, numb

93 that surgical care accounts for 30% of total health care costs, ACOs and policymakers must pay greate

94 I, contribute to adverse health outcomes and health care costs across the entire year after surgery.

95 were associated with significantly increased health care costs after 4 common surgical procedures.

96 reshold, reduces postoperative morbidity and health care costs after cardiac surgery is uncertain.

97 y be responsible for increased morbidity and health care costs after cardiac surgery.

98 Mean total health care costs among patients with CKD without comorb

99 for Medicare and Medicaid Services to reduce health care cost and improve quality.

100 ence of the direction of association between health care cost and quality is inconsistent.

101 (95% CI, $2247-$3558; P < .001) annual total health care costs and $2599 (95% CI, $1985-$3212; P < .0

102 Physicians are attuned to the burden of health care costs and are willing to consider alternativ

103 s, with a concomitant concerning increase in health care costs and burden to children with this disea

104 ciated with a high mortality and substantial health care costs and cause therapeutic problems due to

105 In the current context of rising health care costs and decreasing sustainability, it is b

106 In extreme users, total health care costs and end-of-life health care utilizatio

107 ct cost comparisons between intervention and health care costs and energy savings.

108 disease, or heart failure drive substantial health care costs and increase the proportion of costs a

109 The increased health care costs and morbidity linked to appendiceal ru

110 listic decision analytical model to estimate health care costs and outcomes (quality-adjusted life-ye

111 uly 2012 and March 2013 about causes of high health care costs and proposed cost-control measures.

112 Health care costs and QALYs associated with the current

113 adults with uncontrolled asthma in terms of health care costs and quality-adjusted life years (QALYs

114 Ocular injuries and outcomes and health care costs and reimbursements, which were generat

115 by SCS exposure and quantify the associated health care costs and resource use in patients with seve

116 d data exist on the impact of travel time on health care costs and resource use.

117 The aim of this study was to analyze the health care costs and savings associated with quality im

118 The actual health care costs and theoretical cost differences for t

119 ectomy results in a significant reduction in health care costs and utilization in the short- and long

120 surgery has garnered concern, its impact on health care costs and utilization remains unknown.

121 loping and testing approaches to controlling health care costs and value.

122 e worldwide; in isolation, it doubles annual health care costs and, when associated with comorbid men

123 age, an infected individual incurs US$474 in health-care costs and 0.51 DALYs annually.

124 ly infected individuals is $24.73 billion in health-care costs and 29,385,250 DALYs.

125 rger proportion of economic burden (80.8% of health-care costs and 60.4% of indirect costs), whereas

126 lly, the annual burden is $627.46 million in health-care costs and 806,170 DALYs.

127 Direct health-care costs and DALYs were estimated for coronary

128 We calculated annual and lifetime health-care costs and disability-adjusted life-years (DA

129 dies have shown a clear pattern of increased health-care costs and use associated with frailty.

130 Health-care costs and, importantly, caregiver burden, ar

131 uding improved patient compliance, decreased health care cost, and decreased incidence of hospitaliza

132 may have a positive impact on patient care, health care costs, and antibiotic stewardship.

133 se national health survey, vital statistics, health care costs, and cohort study outcomes data as mod

134 eases and inflict significant economic loss, health care costs, and emotional burdens.

135 h care services, offset the burden of rising health care costs, and enhance the quality of life among

136 stantial costs, including public assistance, health care costs, and income losses due to lower educat

137 llowing postoperative adjustability, reduced health care costs, and less likelihood of inducing aller

138 mately $53.4 billion annually in lost wages, health-care costs, and criminal costs.

139 for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference

140 nd 365 days after the index procedure; total health care costs; and estimated days off from work owin

141 Thus, despite health care cost appearing to be an effective proxy for

142 Physicians' views about health care costs are germane to pending policy reforms.

143 Health care costs are growing faster than the rest of th

144 l effects of smoking status on perioperative health care costs are unclear.

145 re disease because morbidity, mortality, and health-care costs are substantial and the unmet need is

146 gorithms, which balance patient benefits and health care costs, are needed.

147 with CML will have a great effect on future health care costs as long as continuous TKI treatment is

148 y for improved patient care and reduction in health-care costs, as will be further evaluated in futur

149 However, research is lacking on the type of health care costs associated with CKD across all stages

150 g all European countries, the containment of health care costs associated with CS is needed, along wi

151 o determine the lifetime health benefits and health care costs associated with intensive control vers

152 The direct health care costs associated with treatment of adhesion-

153 approach was used to estimate the additional health-care costs associated with human resources, commo

154 spital readmission, all-cause mortality, and health care costs at 1 year (primary) and at 30 days and

155 middle age is strongly associated with lower health care costs at an average of 22 years later in lif

156 d the differential effect of serious SSIs on health care costs at the upper end of the cost distribut

157 Patients desire information about health care costs because they are increasingly responsi

158 with cancer bear a greater portion of their health care costs, because cancer treatment costs have i

159 rates of 6 to 30% and significantly increase health care costs, because of increased length of stay a

160 The mean difference in direct health care costs between groups was pound107.53 ( pound

161 mplicated appendicitis, disability days, and health care costs between nonoperative management and su

162 antial burden in terms of high incidence and health care costs but is excluded by most cancer registr

163 Surgical site infections (SSIs) may increase health care costs, but few studies have conducted an ana

164 to all indicated patients would increase US health care costs by approximately $10 billion over 5 ye

165 ergency, pharmaceutical, dialysis, and total health care costs by eGFR (Kidney Disease Improving Glob

166 an integrated delivery system, we evaluated health care costs by expenditure type in general and in

167 nd private initiatives have sought to reduce health care costs by making health care prices more tran

168 centres reduced mortality by 94%, increased health-care costs by 33%, and was cost-effective (ICER $

169 otential for improving outcomes and reducing health-care costs by eliminating unnecessary invasive pr

170 g patients but also save direct and indirect health-care costs by streamlining procedures, minimizing

171 al and deep/organ space SSIs incurred higher health care costs C$20,648 (95% CI C$16,980- C$24,112and

172 f reduced systolic blood pressure to 10-year health-care costs, cardiovascular disease events, and mo

173 is would prevent over $1.1 billion in direct health care costs compared to a typical season, based on

174 t study was performed using the Pennsylvania Health Care Cost Containment Council database during 01/

175 t study was performed using the Pennsylvania Health Care Cost Containment Council database of all res

176 procedure volume data from the Pennsylvania Health Care Cost Containment Council, we calculated prox

177 In this survey about health care cost containment, US physicians reported hav

178 The overall health care cost could have decreased by $293.61 per pat

179 data indicated that injection frequency and health care costs did not differ for anti-VEGF treatment

180 Total mean health care costs did not differ significantly between t

181 Compared with never smokers, health care costs during the first year after hospital d

182 Quarterly and yearly total health care costs, ED visits, hospital days, and prescri

183 High health care costs encourage initiatives that avoid overu

184 veloping HCC and DCC, resulting in decreased health care costs, especially in patients with cirrhosis

185 ntly associated with a 1.26-fold increase in health care costs (estimated, $1715; 95% CI, $338-$2853)

186 Health-care cost euro7.3 billion (62% of total costs), p

187 After 2 years of anticoagulation therapy, health care costs (excluding the study drug) of patients

188 Health care costs, excluding the index surgery, were est

189 Health care costs, family responsibilities, psychologica

190 impact of surgical site infections (SSIs) on health care costs following common ambulatory surgical p

191 To evaluate geographic variation in health care cost for management of AKs and the associati

192 breastfeeding as follows: the sum of direct health care costs for diseases whose risk increases when

193 use of laparoscopy is associated with lower health care costs for many operations, including colecto

194 Total initial (emergency department [ED]) health care costs for persons with index firearm injurie

195 nt, were equal to or greater than the actual health care costs for similar proportions of patients an

196 tion, both resulted in a decrease in overall health care costs for the patient cohort.

197 primary care patients, the mean total annual health care costs for the three years after diagnosis co

198 da (which indicate prolonged and even higher health-care costs for patients diagnosed late) suggest t

199 Monthly standardized health care costs from commercial claims data from Janua

200 model to apply SPRINT treatment effects and health care costs from national sources to a hypothetica

201 We estimated health-care costs from expenditure on care in the primar

202 ines in tobacco-related deaths, and diminish health-care costs from tobacco-related diseases.

203 substantially, with exponential increases in health care costs, given the limited and expensive treat

204 Concerns about patient safety, quality, and health care costs have increased demand for outcome meas

205 States and Europe, efforts to reduce soaring health care costs have led to intense scrutiny of both s

206 s create tremendous strains on productivity, health care costs, health disparities, government budget

207 e potential to reduce the malaria burden and health care costs in communities near reservoirs.

208 Given the widespread concerns about rising health care costs in general and the costs of advanced i

209 cardiovascular risk factors, average annual health care costs in later life were incrementally lower

210 study sought to evaluate the association of health care costs in later life with cardiorespiratory f

211 dens in middle age are associated with lower health care costs in later life.

212 indings suggest that to reduce mortality and health care costs in patients with hypertension, CKD pre

213 Bariatric surgery does not reduce overall health care costs in the long term.

214 the major cause of morbidity, mortality, and health care costs in the United States, and possibly aro

215 ported having some responsibility to address health care costs in their practice and expressed genera

216 ations account for substantial morbidity and health-care costs in paediatric and adult onset Crohn's

217 Health-care costs (in UK 2017 prices) and cost-effective

218 , has been the focus of debates about rising health care costs, inappropriate use, and patient safety

219 portant impact on public health reflected in health care costs, including impact on the need for live

220 ice of locking solution would affect overall health care costs, including the cost of locking solutio

221 ucoma medications is low in Taiwan, although health care costs, including the cost of medication, are

222 n the first-line led to significantly higher health care costs (incremental cost of $612 700), result

223 g the effect of cardiorespiratory fitness on health care costs independent of these risk factors.

224 sis of nationwide commercial claims from the Health Care Cost Institute (HCCI) data spanning 2010 and

225 This study uses Health Care Cost Institute data to assess the share of t

226 ecember 31, 2012, made available through the Health Care Cost Institute.

227 accountable care, understanding variation in health care costs is critical to reducing health care sp

228 of RS testing on breast cancer treatment and health care costs is much greater in younger women.

229 s medical conditions and resultant secondary health care costs is not well understood.

230 One driver of increasing health care costs is the use of radiologic imaging proce

231 tic treatment on patient quality of life and health care costs is unknown.

232 Despite concerns about rising costs in health care, cost is rarely an issue discussed by patien

233 Detailed insight into disease-specific health-care costs is critical because it co-determines t

234 lation and future generations, and to reduce health-care costs is inadequately recognised.

235 s, Mydriasert resulted in overall savings in health-care costs, mainly associated with reduced nursin

236 Other outcomes included health care cost measures (adjusted to 2013 dollars).

237 ly; P < .001) and lower appendicitis-related health care costs (median [IQR], $4219 [$2514-$7795] vs

238 gical emergency with considerable associated health-care costs, morbidity, and mortality.

239 ificant contribution of surgical spending to health care costs, most surgeons are unaware of their op

240 ed $100 billion in annual incremental direct health care costs nationwide.

241 The primary outcome was average annual health care costs obtained from Medicare standard analyt

242 national average of $46,400 in attributable health care cost of postoperative pneumonia and a benchm

243 This study aimed to determine the direct health care costs of CRS from the perspective of the US

244 icaid claims analysis compared mean 18-month health care costs of patients with newly diagnosed AR wh

245 disorders of the blood represented an annual health-care cost of euro159 per ten citizens.

246 study aimed to identify what the additional health-care costs of a strategic preparedness and respon

247 provide reliable up-to-date estimates of the health-care costs of excess weight and emphasise the nee

248 ven cost-saving, in settings where long-term health-care costs of late-diagnosed patients in high-pre

249 y experience financial burden as a result of health care costs, particularly because these patients o

250 The overall health care cost per episode was 3 times lower in group

251 nce after the intervention, and unit cost is health care cost per event.

252 mes and Measures: Mean total and AAA-related health care cost per life-year and per quality-adjusted

253 The mean health care cost per patient was $3437.24 ($1334.68).

254 th care services, adjusted mean annual total health care costs per person, and adjusted mean annual n

255 and US$1220 (95% CI: -US$2416, -US$24) lower health-care costs per team diabetes patient in the past

256 both cohorts, as did annual per-beneficiary health care costs (pre-MOC period, $5157 for MOC-require

257 Direct health-care costs, productivity losses, and disability-a

258 care is known to improve outcomes and lower health care costs, prompting recent U.S. policy efforts

259 Lifetime direct health care costs, quality-adjusted life years (QALYs),

260 e bias arises because the algorithm predicts health care costs rather than illness, but unequal acces

261 ree to which such surgery is associated with health care cost reductions that are sustained over time

262 Health care costs remain high at $3.2 trillion spent ann

263 Total health care costs remained higher in the three years aft

264 n Hospital Association Annual Survey and the Health Care Cost Report Information System from the US C

265 Health-care costs, reported in 2017 US dollars, were det

266 Research demonstrates significant health care cost savings conferred by allergen-specific

267 Annual health care cost savings in the United States ranging fr

268 The magnitude of 18-month health care cost savings realized by AIT-treated adults

269 es included reduction in delay to treatment, health care cost savings, and decrease in no-show rate.

270 ve prostate cancer with consequent potential health care cost savings.

271 thresholds and was estimated to increase US health care costs substantially.

272 initiating AIT incurred significantly lower health care costs than matched control subjects beginnin

273 CKD is associated with higher health care costs that increase with disease progression

274 atically improve patient outcomes and reduce health care costs through a shift in focus from disease

275 ity, improving quality of life, and reducing health care costs through early detection of colon cance

276 ors to examine the impact of SSIs on 180-day health care costs throughout the cost distribution.

277 to patients as well as controlling excessive health care costs to both patients and health care facil

278 Escalating health care costs together with questionable efficacy of

279 nd RYGB were associated with flattened total health care cost trajectories but RYGB patients experien

280 Median (interquartile range) total health care costs were $48663 ($32620-$71547) for patien

281 Length of stay and total health care costs were compared using multivariable line

282 When all health care costs were compared, the intervention group'

283 subjects, significantly lower 18-month mean health care costs were demonstrated overall (38%; $6,637

284 Health care costs were determined by multiplying the tot

285 Total health care costs were euro 70,046 (95% credibility inte

286 Adjusted respiratory-related health care costs were significantly lower for HFA-beclo

287 88 person-years of follow-up, average annual health care costs were significantly lower forparticipan

288 djusted differences in total HZ-attributable health-care costs were $4762 and $6705 for commercial/Me

289 Finally, out-of-pocket expenses for indirect health-care costs were a key barrier to accessing surgic

290 Health-care costs were estimated from expenditure on pri

291 Health-care costs were estimated from expenditure on pri

292 ect 0.01 (95% CI -0.03 to 0.04; p=0.787) and health-care costs were marginally reduced with CPAP (- p

293 Programme and health-care costs were modelled to determine cost per DA

294 art failure or cardiac deaths) and increased health-care costs when the value of providing that care

295 The health care costs will double from 2010 ($5.8 billion) i

296 bsequent to interventions, and then compared health care costs with energy savings and intervention c

297 lower costs of surgery, and lower follow-up health-care costs with PKR than TKR.

298 herapy may be a reasonable strategy to limit health care costs without compromising clinical outcomes

299 leading causes of mortality, disability, and health care costs worldwide.

300 ificant associated morbidity, mortality, and health care costs, yet limited data exist detailing tren